Literature DB >> 22266439

Epidemiologic aspects of neural tube defects in South East Iran.

Mohammad Afshar1, Mohammad J Golalipour, Dariush Farhud.   

Abstract

OBJECTIVE: To investigate the rate of neural tube defects (NTDs) and their relation to gender, maternal age, consanguineous marriage, season, and drug consumption in Birjand, Iran.
METHODS: This research was carried out on 16,785 live or stillborn newborns in Birjand, Iran from April 1997 to December 2001.
RESULTS: The rate of NTDs was 2.97 per 1000. This rate was 1.97 per 1000 in males, and 3.55 per 1000 in females. The rate of anencephaly was 1.37 per 1000, and spina bifida was 0.88 per 1000. We found that 32% of mothers with affected newborns had taken drugs during the first trimester of pregnancy, 90% of mothers did not consume folate before and during the first trimester, and 54% of parents had consanguineous marriage.
CONCLUSION: We concluded that folate deficiency, usage of drugs during pregnancy, and consanguineous marriage may play a role of predisposition to NTD.

Entities:  

Year:  2006        PMID: 22266439

Source DB:  PubMed          Journal:  Neurosciences (Riyadh)        ISSN: 1319-6138            Impact factor:   0.906


  10 in total

Review 1.  Global Birth Prevalence of Spina Bifida by Folic Acid Fortification Status: A Systematic Review and Meta-Analysis.

Authors:  Callie A M Atta; Kirsten M Fiest; Alexandra D Frolkis; Nathalie Jette; Tamara Pringsheim; Christine St Germaine-Smith; Thilinie Rajapakse; Gilaad G Kaplan; Amy Metcalfe
Journal:  Am J Public Health       Date:  2015-11-12       Impact factor: 9.308

Review 2.  Prevalence of Congenital Anomalies in Iran: A Review Article.

Authors:  Soudabeh Vatankhah; Mina Jalilvand; Samaneh Sarkhosh; Mina Azarmi; Mohammad Mohseni
Journal:  Iran J Public Health       Date:  2017-06       Impact factor: 1.429

Review 3.  The recurrence risk of genetic complex diseases.

Authors:  Mahdi Bijanzadeh
Journal:  J Res Med Sci       Date:  2017-03-15       Impact factor: 1.852

4.  Birth Defects in Northern Iran (2008-2013).

Authors:  Arezoo Mirfazeli; Nafiseh Kaviany; Kanizreza Hosseinpoor; Mohammad Aryaie; Mohammad Jafar Golalipour
Journal:  Iran J Public Health       Date:  2018-03       Impact factor: 1.429

Review 5.  Weaknesses in the Reporting of Cross-sectional Studies in Accordance with the STROBE Report (The Case of Congenital Anomaly among Infants in Iran): A Review Article.

Authors:  Morvarid Irani; Maryam Hassanzadeh Bashtian; Talat Khadivzadeh; Hosein Ebrahimipour; Seyyed Mohsen Asghari Nekah
Journal:  Iran J Public Health       Date:  2018-12       Impact factor: 1.429

6.  Global prevalence of congenital anencephaly: a comprehensive systematic review and meta-analysis.

Authors:  Nader Salari; Behnaz Fatahi; Reza Fatahian; Payam Mohammadi; Adibeh Rahmani; Niloofar Darvishi; Mona Keivan; Shamarina Shohaimi; Masoud Mohammadi
Journal:  Reprod Health       Date:  2022-10-17       Impact factor: 3.355

7.  Neural tube defects in native fars ethnicity in northern iran.

Authors:  Mj Golalipour; L Najafi; Aa Keshtkar
Journal:  Iran J Public Health       Date:  2010-09-30       Impact factor: 1.429

8.  Incidence and Risk Factors of Neural Tube Defects in Kashan, Central Iran.

Authors:  Ahmad Talebian; Babak Soltani; Mojtaba Sehat; Abolfazl Zahedi; Akram Noorian; Motahhareh Talebian
Journal:  Iran J Child Neurol       Date:  2015

9.  Prevention of neural tube defects by the fortification of flour with folic acid: a population-based retrospective study in Brazil.

Authors:  Leonor Maria Pacheco Santos; Roberto Carlos Reyes Lecca; Juan Jose Cortez-Escalante; Mauro Niskier Sanchez; Humberto Gabriel Rodrigues
Journal:  Bull World Health Organ       Date:  2015-10-27       Impact factor: 9.408

Review 10.  Describing the Prevalence of Neural Tube Defects Worldwide: A Systematic Literature Review.

Authors:  Ibrahim Zaganjor; Ahlia Sekkarie; Becky L Tsang; Jennifer Williams; Hilda Razzaghi; Joseph Mulinare; Joseph E Sniezek; Michael J Cannon; Jorge Rosenthal
Journal:  PLoS One       Date:  2016-04-11       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.